Razadyne and Breastfeeding
No studies have been conducted on Razadyne and breastfeeding, so it is not known whether the drug passes through breast milk. Since the medication is only approved for treating Alzheimer's disease, however, it is unlikely that a woman of childbearing age would need to use Razadyne. Breastfeeding women should always talk to their healthcare providers before taking Razadyne.
Currently, it is not known whether Razadyne® (galantamine hydrobromide) passes through breast milk in humans. As a result, it is a good idea to talk with your healthcare provider before taking Razadyne if you are breastfeeding. It should be noted that Razadyne is approved only for treating Alzheimer's disease, a condition that is unlikely to occur in women of childbearing age.
No studies have been conducted on whether Razadyne passes through breast milk in women. However, based on the chemical properties of Razadyne, it is likely to pass through breast milk. Also, because Razadyne has not been adequately studied in any infants or children, it is not known if Razadyne could have any negative effects on an infant or if it does pass through breast milk.
You should talk with your healthcare provider about Razadyne and breastfeeding. Each woman's situation is different, and you and your healthcare provider understand your situation best. After considering what you want and expect, as well as your current health situation, you and your healthcare provider can make a shared decision about Razadyne and breastfeeding that is right for you.